HCA vs INVA: fair value comparison
HCA Healthcare, Inc. and Innoviva, Inc. · Updated 2026-09-12
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, HCA currently sits closer to the top of our discount ranking. INVA carries the stronger quality grade.
| HCA | INVA | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $426.94 | $21.08 |
| 12-month range | $370.96–$532.92 | $18.11–$23.41 |
| Sector rank | #62 of 113 Healthcare | #63 of 113 Healthcare |
| Quality grade | D | A |
| Leverage | Low | Low |
| Margin trend | Contracting | Contracting |
| Revenue growth | Modest | High |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Downtrend |
| DCF cross-check | Overvalued | Undervalued |
| 52-week position | The lower-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: HCA fair value analysis · INVA fair value analysis